CDSCO gives nod to make generic version of Pfizer’s Covid-19 pill

“This will ensure stability and rapid production and availability of this treatment for the Indian market,” he said.

257
CDSCO gives nod to make generic version of Pfizer’s Covid-19 pill

Last Updated on July 29, 2022 by The Health Master

Hyderabad: Hyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, on Thursday said it has received emergency use authorization (EUA) from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market in India a generic version of Pfizer’s Covid-19 pill Paxlovid for the treatment of patients with mild to moderate Covid-19 symptoms.

The approval is for Nirmatrelvir and Ritonavir tablets in a combi pack and they will be sold under the Paxzen brand in India. The drug is being manufactured at Zenara’s USFDA-approved facility in Hyderabad.

Pointing out that the company was one of the first companies to bring the drug to market in India in record time, Zenara Pharma co-founder and managing director Jagadeesh Babu Rangisetty said the company has its own in-house active pharmaceutical ingredients pipeline for the drug and was not dependent on imports for production of the drug.

“This will ensure stability and rapid production and availability of this treatment for the Indian market,” he said.

The breakthrough approval in the US for Paxlovid was given by the USFDA in December 2021. It is the first oral pill that has been approved by the USFDA and is claimed to have a better safety profile than subsequently approved oral therapies.

Zenara Pharma CEO Dr. Srinivas Arutla said the company expects to launch Paxzen in the next couple of weeks and is in talks with multiple institutions and hospitals in the country to ensure ready availability for patients in need.

Norms for small Pharmaceutical firms may be eased

Govt invites applications to produce Vitamin B1

Drug recall: Magnesium Citrate Oral Solution recalled due to this reason

USFDA gives nod for this generic high Blood Pressure drug

USFDA issues Form 483 for six observations to Granules Pharma

USFDA gives approval for this tablet to treat High BP

No extension in deadline for registration of Medical Devices

NMC directs State Medical Councils to take action against Quacks

FDA Haryana team raided, Codeine syrup recovered, FIR lodged

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news